State Street’s Jupiter Neurosciences JUNS Stock Holding History

State Street’s Portfolio JUNS Stock Details JUNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$35.4K	Buy	+14,500	New	+$101K	﹤0.01%	4205

Other funds holding JUNS

Vestor Capital Chicago, Illinois $1.62B AUM 33.15% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

State Street's JUNS Position: Q3 2026 in Review

State Street opened a new position in Jupiter Neurosciences (JUNS) in Q3 2026: 14,500 shares worth $35.4K. The stake represents ﹤0.01% of the portfolio and ranks #4205 among its holdings.

5 funds tracked by Wall St. Rank hold JUNS as of Q3 2026.

State Street held 14,500 shares of Jupiter Neurosciences worth $35.4K as of Q3 2026.
Jupiter Neurosciences was a new State Street position in Q3 2026.
Jupiter Neurosciences made up ﹤0.01% of State Street's portfolio in Q3 2026, its #4205 holding.
5 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.